Why the study?
Endogenous repair capacity varies greatly after myocardial infarction, prompting a review of how cardiac PET/CT can precisely characterize early pathogenetic processes governing ventricle remodeling and progression to heart failure.
Answers are grounded in this paper and cite their sources.
Cardiac PET/CT molecular imaging offers a noninvasive method to characterize early post-MI inflammation and fibroblast activation, potentially guiding precision therapies to prevent heart failure.
PURPOSE OF REVIEW: Current therapeutic strategies to mitigate heart failure progression after myocardial infarction involve support of endogenous repair through molecular targets. The capacity for repair varies greatly between individuals. In this review, we will assess how cardiac PET/CT enables precise characterization of early pathogenetic processes which govern ventricle remodeling and progression to heart failure. RECENT FINDINGS: Inflammation in the first days after myocardial infarction predicts subsequent functional decline and can influence therapy decisions. The expansion of anti-inflammatory approaches to improve outcomes after myocardial infarction may benefit from noninvasive characterization using imaging. Novel probes also allow visualization of fibroblast transdifferentiation and activation, as a precursor to ventricle remodeling. The expanding arsenal of molecular imaging agents in parallel with new treatment options provides opportunity to harmonize diagnostic imaging with precision therapy.
No takes yet. Share an insight, caveat, or question.
James T. Thackeray (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: